Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

RFK Jr. Says Ice Cream Makers Must Ditch Synthetic Dyes By 2028—What It Means For Major Brands

The U.S. Health Secretary Robert F. Kennedy Jr.‘s announcement that ice cream makers will eliminate synthetic dyes in their formulations could impact the listed ice cream makers who would be required to execute the change.

Benzinga

More elderly Americans are choking to death. Are these devices the answer?

Each year, choking claims the lives of more than 4,100 Americans who are 65 or older

The Independent UK

Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Monday agreed to acquire Monogram Technologies Inc. (NASDAQ:MGRM) for an upfront payment of $4.04 per share, corresponding to an equity value of approximately $177 million and an enterprise value of approximately $168 million.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

ProKidney Just Set a New 52-Week High. Should You Buy, Sell, or Hold PROK Stock Here?

As ProKidney hits a fresh 52-week high, can it sustain momentum through late-stage trials, or should investors stay cautious amid the market’s mixed view?

Barchart

6 FDA Policies That Have Never Been Updated Since the ’70s

The Food and Drug Administration has long stood as one of the most influential regulators in the United States, wielding enormous power over what people eat, drink, and use for medicine. Yet beneath the surface of modern scientific breakthroughs and ever-evolving technology lies a startling reality: some of the policies…

Everybody Loves Your Money

AstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial

AstraZeneca Plc (NASDAQ:AZN) on Monday released topline data from the BaxHTN Phase 3 trial of baxdrostat in patients with uncontrolled or treatment-resistant hypertension.

Benzinga

America's Baby Formula Rules Are Due for an Update

A new effort called Operation Stork Speed aims to fix outdated FDA rules that block alternative baby formulas from reaching U.S. shelves.

Reason

Read news from The Economist, FT, and more,
with one subscription

‘Tremendous uncertainty’ for cancer research as US officials target mRNA vaccines

Amid Trump cuts and state-level backlash, experts worry that progress in messenger RNA vaccines could stall

The Guardian - US

Medtronic Stock Is Climbing Friday: What's Going On?

On Wednesday, the Centers for Medicare Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ultrasound (uRDN) technologies for uncontrolled hypertension. This coverage would be granted under a Coverage with Evidence Development (CED) framework, requiring treatment within…

Benzinga

Why Is Milestone Pharmaceuticals Stock Plunging On Friday?

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) moved closer to potential FDA approval for its Cardamyst (etripamil) nasal spray, an investigational therapy for paroxysmal supraventricular tachycardia (PSVT), as the U.S. Food and Drug Administration (FDA) accepted the company’s response to prior issues.

Benzinga

Bread sold at Kroger and Walmart in a dozen states is under recall for ‘life-threatening’ problem

Hartford Bakery recalled its Lewis Bake Shop Artisan Style half-loaf bread after a packaging error led to undeclared hazelnuts in some loaves.

The Independent UK

Capricor's Lead Duchenne Therapy Hits FDA Regulatory Roadblock

Capricor Therapeutics Inc. (NASDAQ:CAPR) stock is trading lower on Friday.

Benzinga

FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s (NASDAQ:MRNA) supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID-19 vaccine, in children six months through 11 years of age who are at increased risk for COVID-19 disease.

Benzinga

Klotho Stock Delivers 1,222% Biotech Blowout: Opportunity or Bubble?

Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) have soared more than 1000% over the past three months on promising results and breakthrough hopes. Klotho stock was in the spotlight again Thursday after announcing an FDA nod on its ALS treatment candidate.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Grocery Coupon Guide

8 Childhood Treats That Were Pulled for Health Risks

Many of our favorite childhood snacks and candies exist as fond, sugary memories. We remember the commercials, the colorful packaging, and the joy they brought. However, some of these beloved treats were quietly removed from the market not because of low sales, but because they posed genuine health and safety…

The Conversation

The AI therapist will see you now: Can chatbots really improve mental health?

Recently, I found myself pouring my heart out, not to a human, but to a chatbot named Wysa on my phone. It nodded – virtually – asked me how I was feeling and gently suggested trying breathing exercises.

Roll Call

In Sweden, smokeless products drive tobacco harm reduction push - Roll Call

Smoking is the primary driver of tobacco-related deaths and is highly restricted in most Swedish public places.

International Business Times UK

FDA Blueberry Recall Has Now Turned Deadly: Who Are The Most Vulnerable? Here's What You Need To Know

US blueberry recall upgraded to deadly risk due to listeria. UK consumers urged to check imports and watch for symptoms.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

RITZ crackers under recall after ‘life-threatening’ problem is discovered

Mondelēz is recalling four RITZ cracker sandwich cartons after some individually wrapped peanut butter packs were mistakenly labeled as cheese

Bored Panda

“Extremely Toxic”: Stories Of What It’s Really Like Being Around People Who Are Taking Ozempic

Would you be willing to take Ozempic, despite the potential side effects?

Tom’s Guide

Samsung Galaxy Watch 8 review: Skip the standard and go for the Classic

The Samsung Galaxy Watch 8 features a new case design, updated wellness and fitness tools, and Google's useful Gemini AI voice assistant built in. With several models to choose from, we recommend the Classic edition with a rotating bezel and superior battery life.

Clever Dude

9 Health Trends That Quietly Got Recalled

Staying healthy is essential, but not every trend is worth following. Some health trends seem promising at first. They get popular on social media, in gyms, or even in your local grocery store. However, sometimes these trends are recalled or pulled from the market due to safety concerns. This matters…

Kids Ain't Cheap

Dangerous Mix: 8 Medications With Dangerous Side Effects in Kids

123rf.com

International Business Times UK

Mustang Bio Stock Jumps 180% After FDA Grants Orphan Drug Status to Brain Cancer Drug

Mustang Bio stock surged over 180% on Monday after the FDA granted its brain cancer drug candidate an orphan drug designation.

The Guardian - US

Inside RFK Jr’s conflicted attempt to rid America of junk food

‘Maha’ promised to tackle ultra-processed foods – but is it hijacking the food movement instead?

1 … 54 55 56 57

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.